JBJohn K. Bui

John K. Bui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John K. Bui has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • John W. Mellors

    University of Pittsburgh School of Medicine

    2 shared publications
  • Mary F. Kearney

    HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute

    2 shared publications
  • Michele D. Sobolewski

    Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

    2 shared publications
  • Wei Shao

    Advanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research operated by Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America

    2 shared publications
  • Andrew Musick

    HIV Dynamics and Replication Program, National Cancer Institute, Frederick, Maryland, United States of America

    1 shared publication
  • Ann Wiegand

    HIV Dynamics and Replication Program, National Cancer Institute, Frederick, Maryland, United States of America

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

    by John K. Bui, Michele D. Sobolewski, Brandon F. Keele, Jonathan Spindler, Andrew Musick, Ann Wiegand, Brian T. Luke, Wei Shao, Stephen H. Hughes, John M. Coffin, et al.

    The major obstacle to curing HIV infection is the persistence of cells with intact proviruses that can produce replication-competent virus. This HIV reservoir is believed to exist primarily in CD4+ T-cells and is stable despite years of suppressive antiretroviral therapy. A potential mechanism for HIV persistence is clonal expansion of infected cells, but how often such clones carry replication-competent proviruses has been controversial. Here, we used single-genome sequencing to probe for identical HIV sequence matches among viruses recovered in different viral outgrowth cultures and between the sequences of outgrowth viruses and proviral or intracellular HIV RNA sequences in uncultured blood mononuclear cells from eight donors on suppressive ART with diverse proviral populations. All eight donors had viral outgrowth virus that was fully susceptible to their current ART drug regimen. Six of eight donors studied had identical near full-length HIV RNA sequences recovered from different viral outgrowth cultures, and one of the two remaining donors had identical partial viral sequence matches between outgrowth virus and intracellular HIV RNA. These findings provide evidence that clonal expansion of HIV-infected cells is an important mechanism of reservoir persistence that should be targeted to cure HIV infection. Antiretroviral therapy (ART) can reduce plasma HIV viral loads to undetectable levels. However, HIV-infected cells can persist despite years of antiretroviral suppression and contribute to rebound viremia following cessation of ART. It is unclear whether HIV-infected cells are maintained by ongoing viral replication, prolonged survival of infected cells, or clonal expansion of infected cells. No studies to date have definitively determined whether clonal expansion is a common mechanism of persistence for replication-competent HIV. To investigate, we used single-genome sequencing to detect identical HIV sequence matches between replication-competent viruses, proviruses, and/or cell-associated RNA from eight donors who were on long-term suppressive ART without evidence of ongoing viral replication. Six of eight donors had identical near full-length sequences between unique replication-competent viruses. One of the two remaining donors had identical partial viral sequences between a replication-competent virus and cell-associated HIV RNA. These findings suggest that clonal expansion is an important mechanism of persistence of replication-competent HIV and should be targeted by HIV cure efforts.


  • Open Access

    Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells

    by John K. Bui, Elias K. Halvas, Elizabeth Fyne, Michele D. Sobolewski, Dianna Koontz, Wei Shao, Brian Luke, Feiyu F. Hong, Mary F. Kearney, John W. Mellors

    The fate of HIV-infected cells after reversal of proviral latency is not well characterized. Simonetti, et al. recently showed that CD4+ T-cells containing intact proviruses can clonally expand in vivo and produce low-level infectious viremia. We hypothesized that reversal of HIV latency by activation of CD4+ T-cells can lead to the expansion of a subset of virus-producing cells rather than their elimination. We established an ex vivo cell culture system involving stimulation of CD4+ T-cells from donors on suppressive antiretroviral therapy (ART) with PMA/ionomycin (day 1–7), followed by rest (day 7–21), and then repeat stimulation (day 21–28), always in the presence of high concentrations of raltegravir and efavirenz to effectively block new cycles of viral replication. HIV DNA and virion RNA in the supernatant were quantified by qPCR. Single genome sequencing (SGS) of p6-PR-RT was performed to genetically characterize proviruses and virion-associated genomic RNA. The replication-competence of the virions produced was determined by the viral outgrowth assay (VOA) and SGS of co-culture supernatants from multiple time points. Experiments were performed with purified CD4+ T-cells from five consecutively recruited donors who had been on suppressive ART for > 2 years. In all experiments, HIV RNA levels in supernatant increased following initial stimulation, decreased or remained stable during the rest period, and increased again with repeat stimulation. HIV DNA levels did not show a consistent pattern of change. SGS of proviruses revealed diverse outcomes of infected cell populations, ranging from their apparent elimination to persistence and expansion. Importantly, a subset of infected cells expanded and produced infectious virus continuously after stimulation. These findings underscore the complexity of eliminating reservoirs of HIV-infected cells and highlight the need for new strategies to kill HIV-infected cells before they can proliferate. Stable latent reservoirs of HIV persist despite suppressive antiretroviral therapy (ART) and cause rebound viremia following interruption of ART. New HIV cure strategies aim to deplete the latent reservoir by reversing HIV latency and promoting the death of cells containing inducible proviruses. Multiple latency reversing agents have been discovered, with the most effective compounds also causing T-cell activation. We investigated the ex vivo effects of cell activation on HIV-infected cells from individuals on stable suppressive ART. Latency reversal through robust cell activation led to diverse outcomes of infected cells. Although many infected cells appeared to be eliminated following T-cell activation, a subset of HIV-infected cells persisted and could expand, including those that can produce infectious virus. These findings highlight the need for new therapies that kill HIV-infected cells before they can proliferate.